|
Title
|
|
|
|
Safety of centrifugal left ventricular assist device in patients previously treated with MitraClip system
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Introduction: No data regarding the safety of continuous-flow left ventricular assist device (CF-LVAD) implantation in patients with previous MitraClip have been reported. Thus, it remains unknown whether an initial treatment strategy with MitraClip therapy might complicate future heart failure management in patients who are also considered for CF-LVAD. Methods: We retrospectively identified 6 patients (median age of 62 years; 2 women) who had been treated with MitraClip, that were eventually implanted with a CF-LVAD (all Heartware HVAD) in 3 hospitals between 2013 and 2018. Results: Patients were treated in 4 cases with 2 clips, and in 2 cases with 1 clip. Median time from MitraClip implantation to CF-LVAD implant was 282 days (interquartile range 67 to 493), and median time on CF-LVAD support was 401 days (interquartile range 105 to 492 days). Two patients underwent a heart transplant, 3 patients died on support, and 1 is alive on support. In all cases, there was a reduction of functional mitral regurgitation without MitraClip-related complications. Conclusions: Based on this small case series, implantation of a CF-LVAD appears safe in patients with a previously positioned MitraClip system, at least, with 1 or 2 clips in place, with no need for additional mitral valve surgery. (c) 2019 Elsevier B.V. All rights reserved. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
International journal of cardiology. - Amsterdam, 1981, currens
| |
|
Publication
|
|
|
|
Amsterdam
:
2019
| |
|
ISSN
|
|
|
|
0167-5273
| |
|
DOI
|
|
|
|
10.1016/J.IJCARD.2019.02.039
| |
|
Volume/pages
|
|
|
|
283
(2019)
, p. 131-133
| |
|
ISI
|
|
|
|
000461330100028
| |
|
Pubmed ID
|
|
|
|
30833105
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|